| Product Code: ETC6683858 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Cape Verde continues to heavily rely on imports for non-alcoholic steatohepatitis (NASH) biomarkers, with top exporting countries in 2024 being Portugal, Italy, Senegal, Areas, nes, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market landscape. Despite a strong compound annual growth rate (CAGR) of 16.93% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -28.87%. This suggests a potential shift or challenge in the market dynamics for NASH biomarkers in Cape Verde.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Cape Verde Country Macro Economic Indicators |
3.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2022 & 2032F |
3.3 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2022 & 2032F |
3.6 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Cape Verde |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of NASH |
4.2.3 Technological advancements in biomarker development for NASH |
4.3 Market Restraints |
4.3.1 Lack of awareness about NASH biomarkers among healthcare professionals and patients in Cape Verde |
4.3.2 Limited availability of diagnostic facilities and expertise in NASH diagnosis |
4.3.3 High cost associated with NASH biomarker testing and diagnosis |
5 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2022 - 2032F |
6.1.3 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2022 - 2032F |
6.1.4 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2022 - 2032F |
6.1.5 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2022 - 2032F |
6.1.6 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2022 - 2032F |
6.1.7 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.2.3 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2022 - 2032F |
6.2.4 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2022 - 2032F |
7 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of NASH biomarker tests conducted annually in Cape Verde |
8.2 Adoption rate of NASH biomarkers by healthcare facilities in Cape Verde |
8.3 Rate of increase in NASH diagnosis and treatment following the introduction of biomarker testing |
8.4 Average time taken for NASH biomarker test results to be processed and reported |
8.5 Number of research studies and publications on NASH biomarkers specific to the Cape Verdean population |
9 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2022 & 2032F |
9.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2025 |
10.2 Cape Verde Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here